{"id":"W4405364924","doi":"10.1016/j.msard.2024.106115","title":"154. Efficacy and Safety of Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Results From the Phase 3 GEMINI 1 and 2 Trials","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); University of Toronto; St. Michael's Hospital","funders":"","keywords":"Teriflunomide; Multiple sclerosis; Medicine; Phase (matter); Internal medicine; Oncology; Fingolimod; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006177825,0.0002444858,0.0005576356,0.0001216405,0.0001978726,0.00007931483,0.00005685454,0.0001863532,0.00002501862],"category_scores_gemma":[0.001212456,0.0001596902,0.000105811,0.0002957285,0.0002702287,0.0001336771,0.00006442597,0.0002695901,0.000002574838],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000596522,"about_ca_system_score_gemma":0.00007834289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002007408,"about_ca_topic_score_gemma":0.0004653275,"domain_scores_codex":[0.9980625,0.0001547531,0.0008435201,0.0005326459,0.0001612626,0.0002453562],"domain_scores_gemma":[0.9969381,0.002482487,0.0001655172,0.0002575159,0.00002935367,0.0001270297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03234661,0.00136792,0.05162851,0.0002248283,0.002469453,0.00002318097,0.02907837,0.0002577437,0.03782734,0.0001396385,0.001658967,0.8429775],"study_design_scores_gemma":[0.2144304,0.001179953,0.7472004,0.00653977,0.002362174,0.000007803375,0.006078707,0.01245128,0.001104848,0.0001487395,0.007963703,0.000532162],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9699559,0.02444684,0.00001707903,0.0027919,0.0004675685,0.001062783,0.0005810275,0.0000624461,0.0006144569],"genre_scores_gemma":[0.9816458,0.01754018,0.0003265495,0.00005563588,0.00004351827,0.00003815652,0.0002402093,0.00003336885,0.00007653919],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8424453,"threshold_uncertainty_score":0.6511976,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06294736156404931,"score_gpt":0.3237788504028992,"score_spread":0.2608314888388499,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}